{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:04:11Z","timestamp":1785391451734,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10384-025-01212-4","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T03:54:39Z","timestamp":1747281279000},"page":"681-686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating efficacy of 0.125% atropine using a myopia progression machine learning model"],"prefix":"10.1007","volume":"69","author":[{"given":"Chang Yoon","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa Ra","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9048-551X","authenticated-orcid":false,"given":"Dae Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"1212_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1350-9462(02)00063-0","volume":"22","author":"NA McBrien","year":"2003","unstructured":"McBrien NA, Gentle A. Role of the sclera in the development and pathological complications of myopia. Prog Retin Eye Res. 2003;22:307\u201338.","journal-title":"Prog Retin Eye Res"},{"key":"1212_CR2","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1136\/bjophthalmol-2015-307724","volume":"100","author":"AR Rudnicka","year":"2016","unstructured":"Rudnicka AR, Kapetanakis VV, Wathern AK, Logan NS, Gilmartin B, Whincup PH, et al. Global variations and time trends in the prevalence of childhood myopia, a systematic review and quantitative meta-analysis: implications for aetiology and early prevention. Br J Ophthalmol. 2016;100:882\u201390.","journal-title":"Br J Ophthalmol"},{"key":"1212_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036\u201342.","journal-title":"Ophthalmology"},{"key":"1212_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","volume":"62","author":"IG Morgan","year":"2018","unstructured":"Morgan IG, French AN, Ashby RS, Guo X, Ding X, He M, et al. The epidemics of myopia: aetiology and prevention. Prog Retin Eye Res. 2018;62:134\u201349.","journal-title":"Prog Retin Eye Res"},{"key":"1212_CR5","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3341\/jkos.2016.57.9.1430","volume":"57","author":"S Il Jung","year":"2016","unstructured":"Il Jung S, Han J, Won Kwon J, Gyun Kim D, Hee Kim D, Taek Lim H, et al. Analysis of myopic progression in childhood using the Korea national health and nutrition examination survey. J Korean Ophthalmol Soc. 2016;57:1430\u20134.","journal-title":"J Korean Ophthalmol Soc."},{"key":"1212_CR6","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1038\/ncomms11008","volume":"7","author":"Q Fan","year":"2016","unstructured":"Fan Q, Verhoeven VJM, Wojciechowski R, Barathi VA, Hysi PG, Guggenheim JA, et al. Meta-analysis of gene-environment-wide association scans accounting for education level identifies additional loci for refractive error. Nat Commun. 2016;7:11008.","journal-title":"Nat Commun"},{"key":"1212_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107778","volume":"188","author":"XB Cai","year":"2019","unstructured":"Cai XB, Shen SR, Chen DF, Zhang Q, Jin ZB. An overview of myopia genetics. Exp Eye Res. 2019;188: 107778.","journal-title":"Exp Eye Res"},{"key":"1212_CR8","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho P, Cheung SW. Retardation of myopia in orthokeratology (ROMIO) study: A 2-year randomized clinical trial. Investig Ophthalmol Vis Sci. 2012;53:7077\u201385.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1212_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2 myopia control with atropine 0.01% eyedrops. Ophthalmology. 2016;123:391\u20139.","journal-title":"Ophthalmology"},{"key":"1212_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","volume":"129","author":"JC Yam","year":"2022","unstructured":"Yam JC, Zhang XJ, Zhang Y, Wang YM, Tang SM, Li FF, et al. Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report. Ophthalmology. 2022;129:308\u201321.","journal-title":"Ophthalmology"},{"key":"1212_CR11","first-page":"29","volume":"36","author":"X Han","year":"2021","unstructured":"Han X, Liu C, Chen Y, He M. Myopia prediction: a systematic review. Eye. 2021;36:29\u201333.","journal-title":"Eye"},{"key":"1212_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/ijerph17020463","volume":"17","author":"X Yang","year":"2020","unstructured":"Yang X, Chen G, Qian Y, Wang Y, Zhai Y, Fan D, et al. Prediction of myopia in adolescents through machine learning methods. Int J Environ Res Public Health. 2020;17:463.","journal-title":"Int J Environ Res Public Health"},{"key":"1212_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41746-023-00752-8","volume":"6","author":"LL Foo","year":"2023","unstructured":"Foo LL, Lim GYS, Lanca C, Wong CW, Hoang QV, Zhang XJ, et al. Deep learning system to predict the 5-year risk of high myopia using fundus imaging in children. npj Digit Med. 2023;6:10.","journal-title":"npj Digit Med"},{"key":"1212_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40123-021-00450-2","volume":"11","author":"SM Li","year":"2022","unstructured":"Li SM, Ren MY, Gan J, Zhang SG, Kang MT, Li H, et al. Machine learning to determine risk factors for myopia progression in primary school children: the Anyang childhood eye study. Ophthalmol Ther. 2022;11:573\u201385.","journal-title":"Ophthalmol Ther"},{"key":"1212_CR15","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0886-3350(01)01214-7","volume":"27","author":"A Vogel","year":"2001","unstructured":"Vogel A, Dick HB, Krummenauer F. Reproducibility of optical biometry using partial coherence interferometry: intraobserver and interobserver reliability. J Cataract Refract Surg. 2001;27:1961\u20138.","journal-title":"J Cataract Refract Surg"},{"key":"1212_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00417-019-04290-6","volume":"257","author":"P Sanz Diez","year":"2019","unstructured":"Sanz Diez P, Yang L-H, Lu M-X, Wahl S, Ohlendorf A. Growth curves of myopia-related parameters to clinically monitor the refractive development in Chinese schoolchildren. Graefes Arch Clin Exp Ophthalmol. 2019;257:1045\u201353.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1212_CR17","unstructured":"Kim DH, Lim HT. Development of a prediction model for childhood myopia progression using machine learning technology. University of Ulsan; 2020. https:\/\/oak.ulsan.ac.kr\/handle\/2021.oak\/6674. Accessed 28 April 2025 (in Korean)"},{"key":"1212_CR18","unstructured":"Kim DH, Kim J, Suh Y-W. Development of a prediction model for childhood myopia progression using machine learning technology. Abstract presented at: The 127th American Academy of Ophthalmology Annual Meeting; November 3-6, 2023; San Francisco, USA. https:\/\/aao.scientificposters.com\/apprizr.cfm?RrzWwdpkpWIxzN2YVGD1KPJSTR%2FgBkYZOLOZuptOgtj3p%2BSmCmCvxy3eDtdPQsDqT0oDU%2FqnGb4%3D. Accessed 28 April 2025"},{"key":"1212_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3928\/01913913-20181003-01","volume":"56","author":"DH Kim","year":"2019","unstructured":"Kim DH, Lim HT. Myopia growth chart based on a population-based survey (KNHANES IV-V): a novel prediction model of myopic progression in childhood. J Pediatr Ophthalmol Strabismus. 2019;56:73\u20137.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1212_CR20","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00417-023-06328-2","volume":"262","author":"MC Kim","year":"2023","unstructured":"Kim MC, Kim DH. Verification of a nationwide population-based myopia growth chart in a large longitudinal cohort of 1155 Korean children. Graefes Arch Clin Exp Ophthalmol. 2023;262:1647\u201352.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1212_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm14020175","volume":"14","author":"NC Hansen","year":"2024","unstructured":"Hansen NC, Hvid-Hansen A, M\u00f8ller F, Bek T, Larsen DA, Jacobsen N, et al. Two-year results of 0.01% atropine eye drops and 0.1% loading dose for myopia progression reduction in Danish children: a placebo-controlled, randomized clinical trial. J Pers Med. 2024;14:1\u201314.","journal-title":"J Pers Med"},{"key":"1212_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-023-03177-9","volume":"23","author":"NC Hansen","year":"2023","unstructured":"Hansen NC, Hvid-Hansen A, M\u00f8ller F, Bek T, Larsen DA, Jacobsen N, et al. Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety. BMC Ophthalmol. 2023;23:1\u201311.","journal-title":"BMC Ophthalmol"},{"key":"1212_CR23","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam JC, Li FF, Zhang X, Tang SM, Yip BHKK, Kam KW, et al. Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report. Ophthalmology. 2020;127:910\u20139.","journal-title":"Ophthalmology"},{"key":"1212_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2). Ophthalmology. 2012;119:347\u201354.","journal-title":"Ophthalmology"},{"key":"1212_CR25","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.3390\/jcm13175003","volume":"13","author":"JS Min","year":"2024","unstructured":"Min JS, Min BM. The effect of alternating monocular instillation of 0.125% atropine in Korean children with progressive myopia. J Clin Med. 2024;13:5003.","journal-title":"J Clin Med"},{"key":"1212_CR26","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.3390\/jcm12165220","volume":"12","author":"ZR Chen","year":"2023","unstructured":"Chen ZR, Chen SC, Wan TY, Chuang LH, Chen HC, Yeh LK, et al. Treatment of myopia with atropine 0.125% once every night compared with atropine 0.125% every other night: a Pilot Study. J Clin Med. 2023;12:5003.","journal-title":"J Clin Med"},{"key":"1212_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3341\/jkos.2022.63.5.455","volume":"63","author":"J Yoon","year":"2022","unstructured":"Yoon J, Ha SG, Suh Y, Kim SH. Efficacy of low-dose atropine eyedrops in myopic progression in elementary school children. J Korean Ophthalmol Soc. 2022;63:455\u201360.","journal-title":"J Korean Ophthalmol Soc"},{"key":"1212_CR28","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","volume":"113","author":"W-HH Chua","year":"2006","unstructured":"Chua W-HH, Balakrishnan V, Chan Y-HH, Tong L, Ling Y, Quah B-LL, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113:2285\u201391.","journal-title":"Ophthalmology"},{"key":"1212_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","volume":"65","author":"O Hieda","year":"2021","unstructured":"Hieda O, Hiraoka T, Fujikado T, Ishiko S, Hasebe S, Torii H, et al. Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study. Jpn J Ophthalmol. 2021;65:315\u201325.","journal-title":"Jpn J Ophthalmol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01212-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-025-01212-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-025-01212-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:52:53Z","timestamp":1757170373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-025-01212-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1212"],"URL":"https:\/\/doi.org\/10.1007\/s10384-025-01212-4","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C. Y. Han, None; S. R. Kim, None; D. H. Kim, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}